{"entity":{"type":"insider","cik":"0001574589","url":"/insider/0001574589","json_url":"/insider/0001574589.json","name":"Curnutte John T","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":13,"first":"2014-06-16","last":"2017-07-20","span_basis":"filed_date"},"name_variants":[{"name":"Curnutte John T","source":"filing","n_filings":13,"first_seen":"2014-06-16","last_seen":"2017-07-20"}],"transactions":[{"id":5120380,"accession":"0001209191-17-045853","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-045853","line_url":"/filing/0001209191-17-045853#line-2","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574589","owner_name":"Curnutte John T","owner_display_name":"Curnutte John T","owner_url":"/insider/0001574589","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":650000.0,"total_display":"650,000.00","total_whole":"650,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-18","filed_date":"2017-07-20","scope":"insider"},{"id":4162667,"accession":"0001209191-17-042166","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-17-042166","line_url":"/filing/0001209191-17-042166","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574589","owner_name":"Curnutte John T","owner_display_name":"Curnutte John T","owner_url":"/insider/0001574589","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":57.8825835,"price_display":"57.88","price_state":"stated","total_value":3472955.01,"total_display":"3,472,955.01","total_whole":"3,472,955","shares_owned_after":13802.0,"shares_owned_after_display":"13,802","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-26","filed_date":"2017-06-28","scope":"insider","n_lines":6},{"id":8225479,"accession":"0001209191-15-061013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-061013","line_url":"/filing/0001209191-15-061013#line-2","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574589","owner_name":"Curnutte John T","owner_display_name":"Curnutte John T","owner_url":"/insider/0001574589","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":500000.0,"total_display":"500,000.00","total_whole":"500,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-15","filed_date":"2015-07-15","scope":"insider"},{"id":8885894,"accession":"0001209191-15-055484","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-055484","line_url":"/filing/0001209191-15-055484#line-2","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574589","owner_name":"Curnutte John T","owner_display_name":"Curnutte John T","owner_url":"/insider/0001574589","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":47.5,"price_display":"47.50","price_state":"stated","total_value":475000.0,"total_display":"475,000.00","total_whole":"475,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-22","filed_date":"2015-06-22","scope":"insider"},{"id":8943243,"accession":"0001209191-15-054408","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-054408","line_url":"/filing/0001209191-15-054408#line-2","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574589","owner_name":"Curnutte John T","owner_display_name":"Curnutte John T","owner_url":"/insider/0001574589","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":450000.0,"total_display":"450,000.00","total_whole":"450,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-16","filed_date":"2015-06-17","scope":"insider"},{"id":8925747,"accession":"0001209191-15-048061","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-048061","line_url":"/filing/0001209191-15-048061#line-2","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574589","owner_name":"Curnutte John T","owner_display_name":"Curnutte John T","owner_url":"/insider/0001574589","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":42.5,"price_display":"42.50","price_state":"stated","total_value":425000.0,"total_display":"425,000.00","total_whole":"425,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-29","filed_date":"2015-05-29","scope":"insider"},{"id":8785711,"accession":"0001209191-15-047734","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-047734","line_url":"/filing/0001209191-15-047734","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574589","owner_name":"Curnutte John T","owner_display_name":"Curnutte John T","owner_url":"/insider/0001574589","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":40.298,"price_display":"40.30","price_state":"stated","total_value":402980.0,"total_display":"402,980.00","total_whole":"402,980","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-28","filed_date":"2015-05-28","scope":"insider","n_lines":2},{"id":8246764,"accession":"0001209191-15-017426","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-017426","line_url":"/filing/0001209191-15-017426#line-2","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574589","owner_name":"Curnutte John T","owner_display_name":"Curnutte John T","owner_url":"/insider/0001574589","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":400000.0,"total_display":"400,000.00","total_whole":"400,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-23","filed_date":"2015-02-23","scope":"insider"},{"id":8900057,"accession":"0001209191-15-015608","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-015608","line_url":"/filing/0001209191-15-015608#line-2","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574589","owner_name":"Curnutte John T","owner_display_name":"Curnutte John T","owner_url":"/insider/0001574589","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":37.5,"price_display":"37.50","price_state":"stated","total_value":375000.0,"total_display":"375,000.00","total_whole":"375,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-18","filed_date":"2015-02-18","scope":"insider"},{"id":8717560,"accession":"0001209191-15-014850","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-014850","line_url":"/filing/0001209191-15-014850#line-2","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574589","owner_name":"Curnutte John T","owner_display_name":"Curnutte John T","owner_url":"/insider/0001574589","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":350000.0,"total_display":"350,000.00","total_whole":"350,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-17","filed_date":"2015-02-17","scope":"insider"},{"id":8532998,"accession":"0001209191-15-013862","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-013862","line_url":"/filing/0001209191-15-013862#line-2","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574589","owner_name":"Curnutte John T","owner_display_name":"Curnutte John T","owner_url":"/insider/0001574589","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":32.5,"price_display":"32.50","price_state":"stated","total_value":325000.0,"total_display":"325,000.00","total_whole":"325,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-13","filed_date":"2015-02-13","scope":"insider"},{"id":6647738,"accession":"0001209191-14-042728","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-14-042728","line_url":"/filing/0001209191-14-042728#line-5","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574589","owner_name":"Curnutte John T","owner_display_name":"Curnutte John T","owner_url":"/insider/0001574589","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":300000.0,"total_display":"300,000.00","total_whole":"300,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-18","filed_date":"2014-06-19","scope":"insider"},{"id":6647730,"accession":"0001209191-14-042728","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-042728","line_url":"/filing/0001209191-14-042728","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574589","owner_name":"Curnutte John T","owner_display_name":"Curnutte John T","owner_url":"/insider/0001574589","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":27.5,"price_display":"27.50","price_state":"stated","total_value":550000.0,"total_display":"550,000.00","total_whole":"550,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-17","filed_date":"2014-06-19","scope":"insider","n_lines":2},{"id":6527232,"accession":"0001209191-14-041731","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-041731","line_url":"/filing/0001209191-14-041731#line-2","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574589","owner_name":"Curnutte John T","owner_display_name":"Curnutte John T","owner_url":"/insider/0001574589","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":25.997,"price_display":"26.00","price_state":"stated","total_value":259970.0,"total_display":"259,970.00","total_whole":"259,970","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-16","filed_date":"2014-06-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001269021","name":"PORTOLA PHARMACEUTICALS INC","url":"/issuer/0001269021","role":"Officer (Executive Vice President)","n_filings":13,"first_seen":"2014-06-16","last_seen":"2017-07-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001574589","retrieved_at":"2026-08-25T18:29:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}